The Price of Cannabis
This week we feature a guest addition by Jim Plamondon, VP of Marketing for Thai Cannabis Corporation in Chiang Mai.
As a driver for change, his focus is on turning Thailand into a ‘platform for …
Entries by PharmOut
Thank you to the 2017 GMP, Engineering & Validation Forum Sponsors
Biodecon Solutions
Biodecon Solutions was established to provide unique, safe and proven biological decontamination and containment solutions for Australia and New Zealand.
Operating in the Pharmaceutical, Bio-Medical, Healthcare, Bio-Technology, Life Science and Food Preparation industries, we …
New Revision of PIC/S GMP Guide (PIC/S PE 009-13) Now Live
On 1st of January 2017, revision 13 of the PIC/S Code of GMP for medicinal products (PIC/S PE 009-13) entered into force. Four Chapters of PIC/S PE 009-13 were revised to align with the …
10 tips to improve your quality management system
Quality Management System Documents
A well-written document with a comprehensive and well designed Quality Management System (QMS) can be a manager’s best friend. They are our daily guidance and instructions for our staff, the ‘go-to’ …
How to apply for a medicinal cannabis licence
On October 31, the ODC released an online smart form as well as “flat” paper forms to apply for a cultivation, production or research medicinal cannabis licence. This online form can also be used …
Bob Tribe assisting Saudi Arabian FDA application for PIC/S membership
Last week, Bob Tribe, who is an Executive Consultant with PharmOut spent the week in Riyadh, Saudi Arabia assisting the GMP Inspections Section of the Saudi FDA get ready to lodge an application for …
TGA – medicinal cannabis GMP compliance guideline
Today the TGA just released a new medicinal cannabis GMP compliance guide titled “Guidance on GMP compliance for the manufacture of medicinal cannabis for supply under ‘approved access’ provisions”.
Not sure there would be any experienced …
Funding hits Australian life science research
Last week MTPConnect announced grants worth $7.4 million for 14 national projects supporting the growth of the medical technologies, biotechnologies and pharmaceuticals sector so all of the Australian life science research sector.
This is an exciting announcement from …
Medicinal cannabis licensing and regulations in a (large) nut shell
The recent scheduling changes to medicinal cannabis, which includes cannabidiol (abbreviated as “CBD”) and tetrahydrocannabinols (“THC”), moving it from Schedule 9 (prohibited substance) to Schedule 8 (controlled substance). This change, coupled with the rapidly …
Making sense of the scheduling change to medicinal cannabis
For anyone watching the legislative changes around medicinal cannabis which includes Cannabidiol (CBD) and tetrahydrocannabinols (THC) in Australia the announcement yesterday (August 31st) that changes to the national classification for cannabis scheduling has occurred …